Skip to main content

Advertisement

Log in

Epilepsy and quality of life: what does really matter?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Purpose

To assess quality of life (QoL) in adult people with epilepsy (PWE) and identify the main factors affecting it.

Methods

We enrolled consecutively 122 PWE. They were interviewed for a careful collection of demographic and clinical data. Patients completed dedicated questionnaires for the assessment of the quality of life (Quality of Life in Epilepsy Scale-31) (Q31) as well as psychosocial features: depressive symptoms (DS) (Beck Depression Inventory-II/BDI-II), difficulties of emotion regulation (Difficulties of Emotion Regulation Scale/DERS), and stigma related to epilepsy (Stigma Scale of Epilepsy/SSE and Jacoby’s Stigma Scale/JSS). The results of Q31 and their subscales were correlated with clinical details of PWE, as well as the other scores. A stepwise multiple regression analysis was applied to identify the main factors affecting QoL.

Results

Quality of life is inversely correlated mostly with psychosocial features, as DS, emotion dysregulation, and stigma perception, as well as with epilepsy-related factors, as the seizure frequency and number of antiseizure medications (ASMs). The combination of DS, perceived stigma, and number of ASMs best explained the QoL. Worse features of QoL were detected in females and in patients with age of epilepsy onset in adulthood.

Conclusion

Quality of life in adult PWE is predominantly affected by psychosocial factors more than epilepsy-related ones. These findings suggest that effective epilepsy management requires more than seizure control, and early detection of psychological dysfunction and tailored interventions to improve the QoL should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization (1997). Measuring Quality of Life: the World Health Organization Quality of Life Instruments. WHO/MSA/MNH/PSF; 1–15

  2. Fiest KM, Sauro KM, Wiebe S et al (2017) Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology; 88:296–303.

  3. Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey ER, Elbaz A, Ellenbogen RG, Fisher JL, Fitzmaurice C, Giussani G, Glennie L, James SL, Johnson CO, Kassebaum NJ, Logroscino G, Marin B, Mountjoy-Venning WC, Nguyen M, Ofori-Asenso R, Patel AP, Piccininni M, Roth GA, Steiner TJ, Stovner LJ, Szoeke CEI, Theadom A, Vollset SE, Wallin MT, Wright C, Zunt JR, Abbasi N, Abd-Allah F, Abdelalim A, Abdollahpour I, Aboyans V, Abraha HN, Acharya D, Adamu AA, Adebayo OM, Adeoye AM, Adsuar JC, Afarideh M, Agrawal S, Ahmadi A, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Akinyemi RO, Akseer N, al-Eyadhy A, al-Shahi Salman R, Alahdab F, Alene KA, Aljunid SM, Altirkawi K, Alvis-Guzman N, Anber NH, Antonio CAT, Arabloo J, Aremu O, Ärnlöv J, Asayesh H, Asghar RJ, Atalay HT, Awasthi A, Ayala Quintanilla BP, Ayuk TB, Badawi A, Banach M, Banoub JAM, Barboza MA, Barker-Collo SL, Bärnighausen TW, Baune BT, Bedi N, Behzadifar M, Behzadifar M, Béjot Y, Bekele BB, Belachew AB, Bennett DA, Bensenor IM, Berhane A, Beuran M, Bhattacharyya K, Bhutta ZA, Biadgo B, Bijani A, Bililign N, Bin Sayeed MS, Blazes CK, Brayne C, Butt ZA, Campos-Nonato IR, Cantu-Brito C, Car M, Cárdenas R, Carrero JJ, Carvalho F, Castañeda-Orjuela CA, Castro F, Catalá-López F, Cerin E, Chaiah Y, Chang JC, Chatziralli I, Chiang PPC, Christensen H, Christopher DJ, Cooper C, Cortesi PA, Costa VM, Criqui MH, Crowe CS, Damasceno AAM, Daryani A, de la Cruz-Góngora V, de la Hoz FP, de Leo D, Demoz GT, Deribe K, Dharmaratne SD, Diaz D, Dinberu MT, Djalalinia S, Doku DT, Dubey M, Dubljanin E, Duken EE, Edvardsson D, el-Khatib Z, Endres M, Endries AY, Eskandarieh S, Esteghamati A, Esteghamati S, Farhadi F, Faro A, Farzadfar F, Farzaei MH, Fatima B, Fereshtehnejad SM, Fernandes E, Feyissa GT, Filip I, Fischer F, Fukumoto T, Ganji M, Gankpe FG, Garcia-Gordillo MA, Gebre AK, Gebremichael TG, Gelaw BK, Geleijnse JM, Geremew D, Gezae KE, Ghasemi-Kasman M, Gidey MY, Gill PS, Gill TK, Girma ET, Gnedovskaya EV, Goulart AC, Grada A, Grosso G, Guo Y, Gupta R, Gupta R, Haagsma JA, Hagos TB, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Hankey GJ, Hao Y, Haro JM, Hassankhani H, Hassen HY, Havmoeller R, Hay SI, Hegazy MI, Heidari B, Henok A, Heydarpour F, Hoang CL, Hole MK, Homaie Rad E, Hosseini SM, Hu G, Igumbor EU, Ilesanmi OS, Irvani SSN, Islam SMS, Jakovljevic M, Javanbakht M, Jha RP, Jobanputra YB, Jonas JB, Jozwiak JJ, Jürisson M, Kahsay A, Kalani R, Kalkonde Y, Kamil TA, Kanchan T, Karami M, Karch A, Karimi N, Kasaeian A, Kassa TD, Kassa ZY, Kaul A, Kefale AT, Keiyoro PN, Khader YS, Khafaie MA, Khalil IA, Khan EA, Khang YH, Khazaie H, Kiadaliri AA, Kiirithio DN, Kim AS, Kim D, Kim YE, Kim YJ, Kisa A, Kokubo Y, Koyanagi A, Krishnamurthi RV, Kuate Defo B, Kucuk Bicer B, Kumar M, Lacey B, Lafranconi A, Lansingh VC, Latifi A, Leshargie CT, Li S, Liao Y, Linn S, Lo WD, Lopez JCF, Lorkowski S, Lotufo PA, Lucas RM, Lunevicius R, Mackay MT, Mahotra NB, Majdan M, Majdzadeh R, Majeed A, Malekzadeh R, Malta DC, Manafi N, Mansournia MA, Mantovani LG, März W, Mashamba-Thompson TP, Massenburg BB, Mate KKV, McAlinden C, McGrath JJ, Mehta V, Meier T, Meles HG, Melese A, Memiah PTN, Memish ZA, Mendoza W, Mengistu DT, Mengistu G, Meretoja A, Meretoja TJ, Mestrovic T, Miazgowski B, Miazgowski T, Miller TR, Mini GK, Mirrakhimov EM, Moazen B, Mohajer B, Mohammad Gholi Mezerji N, Mohammadi M, Mohammadi-Khanaposhtani M, Mohammadibakhsh R, Mohammadnia-Afrouzi M, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Mondello S, Moodley Y, Moosazadeh M, Moradi G, Moradi-Lakeh M, Moradinazar M, Moraga P, Moreno Velásquez I, Morrison SD, Mousavi SM, Muhammed OS, Muruet W, Musa KI, Mustafa G, Naderi M, Nagel G, Naheed A, Naik G, Najafi F, Nangia V, Negoi I, Negoi RI, Newton CRJ, Ngunjiri JW, Nguyen CT, Nguyen LH, Ningrum DNA, Nirayo YL, Nixon MR, Norrving B, Noubiap JJ, Nourollahpour Shiadeh M, Nyasulu PS, Ogah OS, Oh IH, Olagunju AT, Olagunju TO, Olivares PR, Onwujekwe OE, Oren E, Owolabi MO, PA M, Pakpour AH, Pan WH, Panda-Jonas S, Pandian JD, Patel SK, Pereira DM, Petzold M, Pillay JD, Piradov MA, Polanczyk GV, Polinder S, Postma MJ, Poulton R, Poustchi H, Prakash S, Prakash V, Qorbani M, Radfar A, Rafay A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahman M, Rahman MHU, Rahman MA, Rajati F, Ram U, Ranta A, Rawaf DL, Rawaf S, Reinig N, Reis C, Renzaho AMN, Resnikoff S, Rezaeian S, Rezai MS, Rios González CM, Roberts NLS, Roever L, Ronfani L, Roro EM, Roshandel G, Rostami A, Sabbagh P, Sacco RL, Sachdev PS, Saddik B, Safari H, Safari-Faramani R, Safi S, Safiri S, Sagar R, Sahathevan R, Sahebkar A, Sahraian MA, Salamati P, Salehi Zahabi S, Salimi Y, Samy AM, Sanabria J, Santos IS, Santric Milicevic MM, Sarrafzadegan N, Sartorius B, Sarvi S, Sathian B, Satpathy M, Sawant AR, Sawhney M, Schneider IJC, Schöttker B, Schwebel DC, Seedat S, Sepanlou SG, Shabaninejad H, Shafieesabet A, Shaikh MA, Shakir RA, Shams-Beyranvand M, Shamsizadeh M, Sharif M, Sharif-Alhoseini M, She J, Sheikh A, Sheth KN, Shigematsu M, Shiri R, Shirkoohi R, Shiue I, Siabani S, Siddiqi TJ, Sigfusdottir ID, Sigurvinsdottir R, Silberberg DH, Silva JP, Silveira DGA, Singh JA, Sinha DN, Skiadaresi E, Smith M, Sobaih BH, Sobhani S, Soofi M, Soyiri IN, Sposato LA, Stein DJ, Stein MB, Stokes MA, Sufiyan M'B, Sykes BL, Sylaja PN, Tabarés-Seisdedos R, te Ao BJ, Tehrani-Banihashemi A, Temsah MH, Temsah O, Thakur JS, Thrift AG, Topor-Madry R, Tortajada-Girbés M, Tovani-Palone MR, Tran BX, Tran KB, Truelsen TC, Tsadik AG, Tudor Car L, Ukwaja KN, Ullah I, Usman MS, Uthman OA, Valdez PR, Vasankari TJ, Vasanthan R, Veisani Y, Venketasubramanian N, Violante FS, Vlassov V, Vosoughi K, Vu GT, Vujcic IS, Wagnew FS, Waheed Y, Wang YP, Weiderpass E, Weiss J, Whiteford HA, Wijeratne T, Winkler AS, Wiysonge CS, Wolfe CDA, Xu G, Yadollahpour A, Yamada T, Yano Y, Yaseri M, Yatsuya H, Yimer EM, Yip P, Yisma E, Yonemoto N, Yousefifard M, Yu C, Zaidi Z, Zaman SB, Zamani M, Zandian H, Zare Z, Zhang Y, Zodpey S, Naghavi M, Murray CJL, Vos T (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459–480. https://doi.org/10.1016/S1474-4422(18)30499-X

    Article  Google Scholar 

  4. Sillanpää M, Schmidt D (2006) Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 129:617–624. https://doi.org/10.1093/brain/awh726

    Article  PubMed  Google Scholar 

  5. Baker GA (1995) Health-related quality-of-life issues: optimizing patient outcomes. Neurology 45:S29–S34

    CAS  PubMed  Google Scholar 

  6. Vingerhoets G (2006) Cognitive effects of seizures. Seizure 15:221–226. https://doi.org/10.1016/j.seizure.2006.02.012

    Article  PubMed  Google Scholar 

  7. Wong ICK, Lhatoo SD (2000) Adverse reactions to new anticonvulsant drugs. Drug Saf 23:35–56. https://doi.org/10.2165/00002018-200023010-00003

    Article  CAS  PubMed  Google Scholar 

  8. Ramaratnam S, Baker GA, Goldstein LH (2008) Psychological treatments for epilepsy. Cochrane Database Syst Rev 16:CD002029. https://doi.org/10.1002/14651858.CD002029.pub3

    Article  Google Scholar 

  9. Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, de Mojà R, Ulivi M, di Lazzaro V (2019) Epilepsy & behavior epilepsy-associated stigma from the perspective of people with epilepsy and the community in Italy. Epilepsy Behav 98:66–72. https://doi.org/10.1016/j.yebeh.2019.06.026

    Article  PubMed  Google Scholar 

  10. Smith D, Baker G, Davies G, Dewey M, Chadwick DW (1993) Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34:312–322. https://doi.org/10.1111/j.1528-1157.1993.tb02417.x

    Article  CAS  PubMed  Google Scholar 

  11. Jacoby A, Baker G, Smith D, Dewey M, Chadwick D (1993) Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Res 16:83–88. https://doi.org/10.1016/0920-1211(93)90042-6

    Article  CAS  PubMed  Google Scholar 

  12. Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B (1998) Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39:81–88. https://doi.org/10.1111/j.1528-1157.1998.tb01278.x

    Article  CAS  PubMed  Google Scholar 

  13. da Silva TI, Ciconelli RM, Alonso NB, Azevedo AM, Westphal-Guitti AC, Pascalicchio TF, Marques CM, Caboclo LOSF, Cramer JA, Sakamoto AC, Yacubian EMT (2007) Validity and reliability of the Portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil. Epilepsy Behav 10:234–241. https://doi.org/10.1016/j.yebeh.2006.08.022

    Article  PubMed  Google Scholar 

  14. Torres X, Arroyo S, Araya S, De Pablo J (1999) The Spanish version of the Quality-of-Life in Epilepsy Inventory (QOLIE- 31): translation, validity, and reliability. Epilepsia 40:1299–1304. https://doi.org/10.1111/j.1528-1157.1999.tb00861.x

    Article  CAS  PubMed  Google Scholar 

  15. May TW, Pfäfflin M, Cramer JA (2001) Psychometric properties of the German translation of the QOLIE-31. Epilepsy Behav 2:106–114. https://doi.org/10.1006/ebeh.2001.0170

    Article  PubMed  Google Scholar 

  16. Beghi E, Niero M, Roncolato M (2005) Validity and reliability of the Italian version of the Quality-of-Life in Epilepsy Inventory (QOLIE-31). Seizure 14:452–458. https://doi.org/10.1016/j.seizure.2005.07.008

    Article  PubMed  Google Scholar 

  17. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-2. 1996.

  18. Sighinolfi C, Norcini Pala A, Chiri LR, Marchetti I, Sica C (2010) Difficulties in Emotion Regulation Scale (DERS): traduzione e adattamento italiano. Psicoter Cogn E Comport 16:141–170

    Google Scholar 

  19. Gratz KL, Roemer L (2004) Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess 26:41–54

  20. Fernandes PT, Salgado PC, Noronha AL, Sander JW, Li LM. (2007) Stigma Scale of Epilepsy: validation process. Arq Neuropsiquiatr; 65; Suppl 1:35–42.

  21. Baker GA, Brooks J, Buck D, Jacoby A (2000) The stigma of epilepsy: a European perspective. Epilepsia 41:98–104. https://doi.org/10.1111/j.1528-1157.2000.tb01512.x

    Article  CAS  PubMed  Google Scholar 

  22. Jacoby A (1994) Felt versus enacted stigma: a concept revisited. Sot Sci Med 38:269–274

    Article  CAS  Google Scholar 

  23. Johnson EK, Jones JE, Seidenberg M, Hermann BP (2004) The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45:544–550. https://doi.org/10.1111/j.0013-9580.2004.47003.x

    Article  PubMed  Google Scholar 

  24. Blond BN, Detyniecki K, Hirsch LJ (2016) Assessment of treatment side effects and quality of life in people with epilepsy. Neurol Clin 34:395–410. https://doi.org/10.1016/j.ncl.2015.11.002

    Article  PubMed  Google Scholar 

  25. Taylor RS, Sander JW, Taylor RJ, Baker GA (2011) Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia 52:2168–2180. https://doi.org/10.1111/j.1528-1167.2011.03213.x

    Article  PubMed  Google Scholar 

  26. Kwon O, Park S (2014) Depression and anxiety in people with epilepsy. J Clin Neurol 10:175–188

    Article  Google Scholar 

  27. Kim M, Kim Y, Kim D et al (2018) Epilepsy & behavior major depressive disorder in epilepsy clinics: a meta-analysis. Epilepsy Behav 84:56–69. https://doi.org/10.1016/j.yebeh.2018.04.015

    Article  PubMed  Google Scholar 

  28. Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, Ulivi M, Di Lazzaro V (2020) Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: association with quality of life and stigma. Epilepsy Behav 107:107073

    Article  Google Scholar 

  29. Jones NC, O’Brien TJ (2013) Stress, epilepsy, and psychiatric comorbidity: how can animal models inform the clinic? Epilepsy Behav 26:363–369. https://doi.org/10.1016/j.yebeh.2012.09.002

    Article  PubMed  Google Scholar 

  30. Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M (2009) A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 72:793–799. https://doi.org/10.1212/01.wnl.0000343850.85763.9c

    Article  CAS  PubMed  Google Scholar 

  31. Tang V, Michaelis R, Kwan P (2014) Psychobehavioral therapy for epilepsy. Epilepsy Behav 32:147–155. https://doi.org/10.1016/j.yebeh.2013.12.004

    Article  PubMed  Google Scholar 

  32. Michaelis R, Tang V, Wagner JL, Modi AC, LaFrance WC Jr, Goldstein LH, Lundgren T, Reuber M (2018) Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life. Epilepsia 59:315–332. https://doi.org/10.1111/epi.13989

    Article  PubMed  Google Scholar 

  33. Gandy M, Sharpe L, Perry KN (2013) Cognitive behavior therapy for depression in people with epilepsy: a systematic review. Epilepsia 54:1725–1734. https://doi.org/10.1111/epi.12345

    Article  PubMed  Google Scholar 

  34. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R (1997) Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38:233–236. https://doi.org/10.1111/j.1528-1157.1997.tb01102.x

    Article  CAS  PubMed  Google Scholar 

  35. Arcot Jayagopal L, Samson KK, Taraschenko O (2018) Driving with drug-resistant and controlled seizures from a patient’s perspective: assessment of attitudes and practices. Epilepsy Behav 81:101–106. https://doi.org/10.1016/j.yebeh.2018.01.023

    Article  PubMed  Google Scholar 

  36. Baker GA, Jacoby A, Buck D et al (1997) Quality of life of people with epilepsy: a European study. Epilepsia 38:353–362. https://doi.org/10.1111/j.1528-1157.1997.tb01128.x

    Article  CAS  PubMed  Google Scholar 

  37. Baranowski CJ (2018) The quality of life of older adults with epilepsy: a systematic review. Seizure 60:190–197. https://doi.org/10.1016/j.seizure.2018.06.002

    Article  PubMed  Google Scholar 

  38. Kuramochi I, Oga K, Iwayama T, Miyawaki Y, Ishihara T, Kobayashi S, Yoshimasu H (2020) Pilot trial of “Epi-school” group psychosocial education program for patients with epilepsy and their relatives in Japan. Epilepsy Behav 113:107545. https://doi.org/10.1016/j.yebeh.2020.107545

    Article  PubMed  Google Scholar 

  39. Edefonti V, Bravi F, Turner K, Beghi E, Canevini MP, Ferraroni M, Piazzini A (2011) Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study. BMC Neurol 11:33. https://doi.org/10.1186/1471-2377-11-33

    Article  PubMed  PubMed Central  Google Scholar 

  40. Tlusta E, Zarubova J, Simko J, Hojdikova H, Salek S, Vlcek J (2009) Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: how this can influence practice. Seizure 18:85–89. https://doi.org/10.1016/j.seizure.2008.06.006

    Article  PubMed  Google Scholar 

  41. Perucca P, Carter J, Vahle V, Gilliam FG (2009) Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 72:1223–1229. https://doi.org/10.1212/01.wnl.0000345667.45642.61

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Jacoby A, Baker GA, Steen N, Pottes P, Chadwick D (1996) The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia 37:148–161

    Article  CAS  Google Scholar 

  43. Bruun E, Kälviäinen R, Keränen T (2016) Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy. Epilepsy Res 127:60–65. https://doi.org/10.1016/j.eplepsyres.2016.08.023

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Emanuele Guerrieri, Filippo Bucciarelli, and Roberta Mojà for their help in collecting data and assisting patients during the administration of questionnaires.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Tombini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol was approved by the local Ethics Committee, and written informed consent was obtained from all participants.

Informed consent

Informed consent was obtained from all individual participants included in the study. The statement was added later.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tombini, M., Assenza, G., Quintiliani, L. et al. Epilepsy and quality of life: what does really matter?. Neurol Sci 42, 3757–3765 (2021). https://doi.org/10.1007/s10072-020-04990-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04990-6

Keywords

Navigation